|
GB8404584D0
(en)
*
|
1984-02-22 |
1984-03-28 |
Beecham Group Plc |
Compounds
|
|
EP0193329A3
(en)
*
|
1985-02-22 |
1987-08-19 |
Beecham Group Plc |
Pyrazolopyridines, their preparation and pharmaceutical compositions containing them
|
|
AT382377B
(de)
*
|
1985-04-27 |
1987-02-25 |
Beecham Group Plc |
Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen
|
|
EP0239191A3
(en)
*
|
1986-01-30 |
1988-07-20 |
Beecham Group Plc |
Pyrazolo[4,3-b]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
|
|
PE20020506A1
(es)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
|
JP2004515550A
(ja)
*
|
2000-12-15 |
2004-05-27 |
グラクソ グループ リミテッド |
治療用化合物
|
|
JP2004518651A
(ja)
|
2000-12-15 |
2004-06-24 |
グラクソ グループ リミテッド |
治療用化合物
|
|
WO2002072581A2
(en)
*
|
2001-03-08 |
2002-09-19 |
Smithkline Beecham Corporation |
Pyrazolopyriadine derivatives
|
|
US7034030B2
(en)
*
|
2001-03-30 |
2006-04-25 |
Smithkline Beecham Corporation |
Pyralopyridines, process for their preparation and use as therapeutic compounds
|
|
WO2002078701A1
(en)
*
|
2001-03-30 |
2002-10-10 |
Smithkline Beecham Corporation |
Use of pyrazolopyridines as therapeutic compounds
|
|
WO2002083672A1
(en)
|
2001-04-10 |
2002-10-24 |
Smithkline Beecham Corporation |
Antiviral pyrazolopyridine compounds
|
|
DE60204452T2
(de)
*
|
2001-04-27 |
2005-12-15 |
Smithkline Beecham Corp. |
Pyrazolo[1,5a]Pyridinderivate
|
|
WO2003000689A1
(en)
*
|
2001-06-21 |
2003-01-03 |
Smithkline Beecham Corporation |
Imidazo`1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
|
JP2005507878A
(ja)
*
|
2001-09-07 |
2005-03-24 |
スミスクライン ビーチャム コーポレーション |
ヘルペス感染症を治療するためのピラゾロ−ピリジン類
|
|
EP1432712B1
(en)
*
|
2001-10-05 |
2006-05-17 |
SmithKline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
|
EP1453830B1
(en)
*
|
2001-12-11 |
2007-09-12 |
SmithKline Beecham Corporation |
Pyrazolo-pyridine derivatives as antiherpes agents
|
|
AU2003275266A1
(en)
*
|
2002-10-03 |
2004-05-04 |
Smithkline Beecham Corporation |
Therapeutic compounds based on pyrazolopyridine derivatives
|
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
|
US7439246B2
(en)
|
2004-06-28 |
2008-10-21 |
Bristol-Myers Squibb Company |
Fused heterocyclic kinase inhibitors
|
|
US7432373B2
(en)
|
2004-06-28 |
2008-10-07 |
Bristol-Meyers Squibb Company |
Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
|
|
US7173031B2
(en)
|
2004-06-28 |
2007-02-06 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US7880004B2
(en)
|
2005-09-15 |
2011-02-01 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
US7547782B2
(en)
|
2005-09-30 |
2009-06-16 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
US9073918B2
(en)
|
2010-05-20 |
2015-07-07 |
Takeda Pharmaceutical Company Limited |
Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5
|
|
KR101590236B1
(ko)
|
2010-12-20 |
2016-01-29 |
화이자 인코포레이티드 |
카세인 키나제 억제제로서의 신규한 융합된 피리딘 화합물
|